Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 May 17;27(10):3194.
doi: 10.3390/molecules27103194.

Neuroinflammatory Markers: Key Indicators in the Pathology of Neurodegenerative Diseases

Abdur Rauf  1 , Himani Badoni  2 , Tareq Abu-Izneid  3 , Ahmed Olatunde  4 , Md Mominur Rahman  5 , Sakshi Painuli  6 , Prabhakar Semwal  7 , Polrat Wilairatana  8 , Mohammad S Mubarak  9
Affiliations
Review

Neuroinflammatory Markers: Key Indicators in the Pathology of Neurodegenerative Diseases

Abdur Rauf et al. Molecules. .

Abstract

Neuroinflammation, a protective response of the central nervous system (CNS), is associated with the pathogenesis of neurodegenerative diseases. The CNS is composed of neurons and glial cells consisting of microglia, oligodendrocytes, and astrocytes. Entry of any foreign pathogen activates the glial cells (astrocytes and microglia) and overactivation of these cells triggers the release of various neuroinflammatory markers (NMs), such as the tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), interleukin-1β (IL-10), nitric oxide (NO), and cyclooxygenase-2 (COX-2), among others. Various studies have shown the role of neuroinflammatory markers in the occurrence, diagnosis, and treatment of neurodegenerative diseases. These markers also trigger the formation of various other factors responsible for causing several neuronal diseases including Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), multiple sclerosis (MS), ischemia, and several others. This comprehensive review aims to reveal the mechanism of neuroinflammatory markers (NMs), which could cause different neurodegenerative disorders. Important NMs may represent pathophysiologic processes leading to the generation of neurodegenerative diseases. In addition, various molecular alterations related to neurodegenerative diseases are discussed. Identifying these NMs may assist in the early diagnosis and detection of therapeutic targets for treating various neurodegenerative diseases.

Keywords: astrocytes; cytokines; inflammation; microglia; neurodegenerative diseases; neuroinflammation.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Veerhuis R., Nielsen H.M., Tenner A.J. Complement in the brain. Mol. Immunol. 2011;48:1592–1603. doi: 10.1016/j.molimm.2011.04.003. - DOI - PMC - PubMed
    1. Monif M., Burnstock G., Williams D.A. Microglia: Proliferation and activation driven by the P2X7 receptor. Int. J. Biochem. Cell Biol. 2010;42:1753–1756. doi: 10.1016/j.biocel.2010.06.021. - DOI - PubMed
    1. Franke H., Verkhratsky A., Burnstock G., Illes P. Pathophysiology of astroglial purinergic signalling. Purinergic. Signal. 2012;8:629–657. doi: 10.1007/s11302-012-9300-0. - DOI - PMC - PubMed
    1. Shastri A., Bonifati D.M., Kishore U. Innate immunity and neuroinflammation. Mediat. Inflamm. 2013;2013:342931. doi: 10.1155/2013/342931. - DOI - PMC - PubMed
    1. Schain M., Kreisl W.C. Neuroinflammation in Neurodegenerative Disorders-a Review. Curr. Neurol. Neurosci. Rep. 2017;17:25. doi: 10.1007/s11910-017-0733-2. - DOI - PubMed